查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840696

全球胃内球囊市场（按类型、最终用户、分销管道和应用）预测 2025-2032

Intragastric Balloon Market by Type, End User, Distribution Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，胃内球囊市场将成长 4,175 万美元，复合年增长率为 8.36%。

主要市场统计数据
基准年2024年 2195万美元
预计2025年 2379万美元
预测年份：2032年 4175万美元
复合年增长率（%） 8.36%

策略性地介绍胃内球囊的演变，强调临床整合、提高安全性和相关人员的采用优先事项

胃内球囊领域正从小众的体重管理替代方案发展成为多学科肥胖治疗途径的主流辅助。器械材料、输送技术和临床通讯协定的进步提高了手术安全性，扩大了临床可接受性，迫使医院和专科诊所重新评估治疗流程。随着相关人员寻求可扩展的解决方案来应对日益增长的肥胖和代谢併发症，胃内球囊在保守药物治疗和减肥手术之间占据着独特的地位，提供了一种可逆的微创治疗方案，可以纳入综合护理计划。

临床结果和患者体验仍然是推广应用的关键。近期的手术优化和术后追踪方案减少了不利事件，并且与行为和药物支持相结合，提高了减重效果的持久性。付款人和医疗系统越来越关注患者的选择标准、现实世界治疗结果的持久性以及与其他治疗方法相比的成本效益。因此，商业策略现在强调可靠的临床证据、精简的供应物流，以及与减重中心、门诊专科诊所和医院系统的伙伴关係，将胃内球囊纳入纵向减重治疗路径。

在这种环境下，製造商和医疗系统领导者必须在设备创新与培训、报销途径和中心准备等实际考量之间取得平衡。不断变化的法规、临床医生教育和患者需求的相互作用，将继续影响不同医疗环境中的定位和应用。

技术进步、综合护理途径和医疗保健服务模式如何改变临床应用和商业性差异化

在技​​术进步、多学科护理模式以及对个人化治疗日益重视的推动下，胃内球囊领域正在发生重大变化。设备创新者改进了填充材、锚定机制和回收技术，并改进了患者选择通讯协定，从而降低了併发症率并扩大了候选对象合格。同时，行为咨商、数位监测和辅助药物治疗的整合已将治疗结果转向更永续的体重管理，鼓励临床医生将水球视为综合治疗策略的一部分，而非一项独立的疗法。

市场动态也在改变。医疗保健机构正在重新配置其服务线，以提供门诊和专科诊所的诊疗服务，从而最大限度地降低医院资源利用率，并提高患者的便利性。同时，製造商正在透过捆绑式价值主张实现差异化，这些主张包括临床医生培训、追踪计画和患者参与工具。儘管监管审查仍然严格，但更清晰的指导方针正在帮助那些正在调整报销框架以认可肥胖干预措施的长期健康经济效益的地区简化相关措施的采用。

因此，竞争正转向注重治疗后疗效、整合的护理路径以及减少医患摩擦的商业模式。这种转变相关人员。

评估美国2025 年关税如何改变整个胃内球囊生态系统的供应链策略、定价透明度和采购惯例

2025年美国关税变化的累积影响正迫使设备製造商、经销商和医疗保健机构采购团队重新评估进口胃内球囊及相关耗材的供应链弹性和成本分摊。关税调整提高了某些类别零件和成品的到岸成本，促使製造商将增加的成本转嫁给下游企业，同时探索替代采购和本地生产以保护利润率。医院和诊所的采购团队正在透过重新谈判合约、寻求更长期的供应协议以及优先选择拥有多元化生产地点的供应商来应对这一挑战。

除了单位成本之外，关税也提升了库存规划和前置作业时间可视性的策略重要性。供应商正越来越多地与分销商合作，以确保可预测的交货，并最大程度地降低关税导致的价格突然波动的风险。一些製造商正在加快对经销商製造能力和第三方伙伴关係的投资，以降低关税风险并提高对临床需求的应对力。法规合规性、海关复杂性和文件要求也消耗了额外的管理资源，促使供应链团队投资于海关专业知识和数位追踪工具。

在这种环境下，强调订单总成本、保固范围和服务水准承诺透明度的商业策略正获得越来越多的支援。积极调整合约实务、对冲供应路线并向买家明确传达成本影响的相关人员，将更有能力在关税带来的不利因素下保持采用势头。

详细的細項分析将设备类型、最终用户设定、通路和临床应用与商业化和临床采用需求联繫起来

了解细分动态对于塑造产品开发和商业性推广至关重要。按类型，对内视镜和非内视镜应用市场进行研究，并进一步研究基于气体和基于液体的应用以用于内视镜应用。这种区别会影响设备设计、程序和安装后管理，并指南哪些临床团队参与培训和跟进。另外，按最终用户，对减肥中心、诊所和医院的市场进行研究。在诊所内，进一步研究了门诊和专科诊所。这些环境中的基础设施、麻醉能力和护理途径的差异决定了首选的设备配置和服务包。此外，基于分销管道，对医院和零售药局的市场进行研究。分销策略必须考虑专业分销经销商在支援库存管理、临床医生采购流程、培训和现场物流方面的作用。最后，根据应用，对术前优化和减重市场进行研究。这种临床细分影响转诊模式、付款人互动和病患支援服务整合。

综合起来，这些细分轴揭示了临床需求的集中点以及商业化努力应在何处进行协调。例如，充气式和液体式内视镜选项对不同的病患小组和手术流程具有吸引力，诊所和门诊专科机构可能会优先考虑能够最大程度缩短手术时间和减少恢復需求的设备。与医院药房的经销伙伴在供应链透明度和临床医生互动方面与零售药房模式有显着差异。基于应用的细分凸显了对术前优化和主要减重结果数据的需求，从而能够向外科医生、基层医疗医生和多学科护理团队通讯。

实际上，製造商需要使其设备功能、培训计划和商业条款与目标区域的主导细分情况保持一致，确保产品变化和服务产品符合最终用户和分销合作伙伴的业务现实。

美洲、欧洲、中东和非洲以及亚太市场的区域采用驱动因素、监管差异和分销需求

区域动态显着影响腹腔内球囊的临床应用模式、监管发展和分销策略。在美洲，随着支付者和医疗服务提供者优先考虑非手术干预措施，越来越多的成熟减重中心和门诊诊所正在将胃内球囊纳入其治疗方案。该地区青睐那些在不同患者群体中表现出可重复结果且可整合到现有多学科肥胖症治疗项目中的解决方案。同时，欧洲、中东和非洲市场差异庞大，法律规范、报销环境和临床实务模式也存在显着差异。虽然集中式医院系统和国家指南推动了某些市场的采用，但在其他市场，支付方覆盖范围和临床医生经验的差异需要有针对性的教育倡议和区域证据的产生。在亚太地区，肥胖和代谢性疾病盛行率的上升、多样化的医疗服务模式以及对微创替代方案的关注，正在推动该技术的快速应用。在多个亚太市场，大量的专科诊所患者和消费者对微创治疗方案的兴趣，促使製造商开发本地化的培训和患者援助计划。

不同地区的供应链、监管时间表和报销途径的成熟度各不相同，这些因素决定了其市场策略。例如，拥有强大门诊医疗网络的地区可能会优先考虑针对当日手术和有限麻醉资源而优化的设备。相反，以院内医疗为主的地区可能会从提供包括临床医生培训、术后监测和长期追踪在内的综合服务中获得更大的收益。有效的区域策略应将全球临床证据与本地相关的真实世界数据和相关人员的参与相结合，以在临床医生、付款人和患者中建立持久的认可。

竞争对手的策略强调设备创新、临床服务捆绑和伙伴关係模式，以推动采用和营运规模

胃内球囊领域的主要企业正围绕着几个策略要点展开整合：临床差异化、服务导向的商业化以及营运扩充性。领先的设备开发商正在投资于设备设计的迭代改进，以减少不利事件并简化放置和移除工作流程。各公司也在扩大其产品组合，涵盖气体和液体填充的内视镜选项，以适应不同的临床医生偏好和患者生理状况。越来越多的公司不仅将设备捆绑销售，还将培训、患者参与平台和后续服务捆绑销售，以改善治疗效果并减轻医务人员的负担。

战略伙伴关係已成为加速应用的热门途径。与减肥中心、专科诊所和分销伙伴的合作，使公司能够在建立转诊网络的同时，展示其在现实世界中的有效性。一些公司正在寻求区域製造合作关係，以提高供应弹性并优化土地成本结构。同时，需要证据生成（前瞻性註册、多中心研究、卫生经济分析）来实现竞争差异化，支持付款人参与并为临床指南提供资讯。成功平衡产品创新、扩充性服务交付和可靠临床证据的公司正在获得大型医疗系统、门诊病人提供者和专科诊所的支持，这些机构寻求可预测的结果和精简的营运。

领导者可以采取切实可行的商业、临床和供应链措施，建立弹性采用路径，并将相关人员置于价值交付的中心

为了促进胃内球囊解决方案的永续应用，产业领导者应优先考虑一种整合方法，将临床证据、服务交付和供应链韧性结合起来。首先，投资于可靠的真实世界证据和患者报告结果，以证实术前优化和独立减重应用中的临床主张，促进付款方讨论和临床医生的认可。其次，根据减重中心、门诊诊所和专科诊所的需求，创建全面的培训和认证路径，减少手术差异并增强安全性。第三，多样化采购和物流策略，以减轻关税波动的影响并缩短前置作业时间。

此外，我们将调整商业模式，透过提供透明的医疗总成本沟通和灵活的合约条款，支持医院和零售药局管道的不同购买行为。我们将利用数位化病人参与工具和多学科支持项目，提高生活方式干预的依从性，并增强追踪能力，同时避免给临床工作人员带来过重负担。最后，我们将与相关人员进行策略合作，建立基于价值的方案和覆盖途径，以反映综合肥胖治疗的长期临床和经济效益。这些措施将强化胃内球囊的价值提案，并实现可持续、可扩展的推广应用。

结合临床访谈、监管审查和供应链分析的综合混合方法研究，检验可行的见解

本报告所依据的研究采用了混合方法，以确保研究结果能反映临床实际情况和商业性动态。主要输入包括对减肥中心、门诊专科诊所和医院计画的临床医生进行结构化访谈，以及与活跃于医院药房和零售药房管道的采购负责人和分销合作伙伴进行讨论。次要输入包括监管出版刊物、临床试验註册中心以及关注设备安全性、有效性和患者报告结果的同行评审文献。透过对这些资料来源进行三角测量，我们能够识别出关于设备性能、操作流程和应用障碍的一致主题。

分析方法包括将器械设计属性（例如填充材和输送系统）与手术结果和护理环境要求进行比较评估。供应链和商业影响分析着重于不同最终用户环境下的采购行为，并包含情境测试，以评估对资费变化和采购中断的回应。研究结果经临床医生顾问小组和供应链专家检验，以确保其具有实际意义，并为製造商、医疗保健提供者和付款相关人员提供切实可行的指导。调查方法和资料来源强调透明度，并优先考虑临床适用性和对决策者的策略效用。

综合结论强调了决定在不同医疗环境中成功采用的临床、商业性和营运槓桿

摘要，胃内球囊已发展成为现代肥胖治疗中具有战略意义的重要工具，其定位介于保守的医疗治疗和外科手术之间。设备创新、临床通讯协定的改进以及整合的护理模式提高了安全性并扩大了应用范围。然而，商业性的成功不仅仅取决于设备的性能；它需要可证明的疗效、清晰的报销途径、弹性的供应链以及支持临床医生培训和患者参与的可扩展服务模式。

不同的关税和区域监管差异带来了复杂性，但也为製造商提供了透过透明定价、本地伙伴关係和循证商业策略实现差异化的机会。透过让产品开发与最终用户需求保持一致——考虑到气体和液体内视镜选项的差异、不同的临床基础设施以及分销管道要求——相关人员可以创建引人入胜的价值提案，引起医疗服务提供者和付款人的共鸣。未来的道路青睐那些将临床严谨性与实用商业化相结合，以实现可重复结果和高效医疗服务的人。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用可调节胃内球囊来实现个人化的体重管理通讯协定
  • 将胃内球囊治疗与数位健康平台结合，实现远端患者监护和参与
  • 开发可生物降解的胃内球囊系统，无需内视镜取出手术
  • 一项评估胃内球囊与GLP-1促效剂合併使用协同减重效果的临床研究
  • 形状记忆聚合物球囊的出现，可根据胃动力的变化进行动态体积调节
  • 新型充气胃内球囊获监理机关核准，可最大程度减少病患不适及手术併发症
  • 增强型胃内球囊应用解决非酒精性脂肪肝和METABOLIC INC.症候群的管理
  • 内视镜设备製造商与远端医疗提供者之间的策略合作伙伴关係扩大了球囊治疗的可及性

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章胃内球囊市场（按类型）

  • 内视镜检查
    • 气体
    • 液体
  • 非内视镜

第九章胃内球囊市场（依最终用户）

  • 肥胖治疗中心
  • 诊所
    • 门诊
    • 专科诊所
  • 医院

第 10 章胃内球囊市场（依通路）

  • 医院药房
  • 零售药局

第11章胃内球囊市场（依应用）

  • 术前优化
  • 减重

第十二章胃内球囊市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章胃内球囊市场：依类别

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各国胃内球囊市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Apollo Endosurgery, Inc.
    • Allurion Technologies, Inc.
    • Obalon Therapeutics, Inc.
    • ReShape Lifesciences, Inc.
    • Spatz Medical, Inc.
    • MedSil, UAB
    • Silimed, SA
    • ENDALIS GmbH
    • GI Dynamics, Inc.
    • BARIATRX Ltd.
Product Code: MRR-7C5681F8681E

The Intragastric Balloon Market is projected to grow by USD 41.75 million at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 21.95 million
Estimated Year [2025] USD 23.79 million
Forecast Year [2032] USD 41.75 million
CAGR (%) 8.36%

Strategic introduction to intragastric balloon evolution highlighting clinical integration, safety improvements, and stakeholder priorities for adoption

The intragastric balloon segment has evolved from a niche alternative for weight management into a mainstream adjunct within multidisciplinary obesity care pathways. Advances in device materials, delivery techniques, and clinical protocols have increased procedural safety and broadened clinical acceptance, prompting hospitals and specialty clinics to re-evaluate treatment algorithms. As stakeholders seek scalable solutions to address rising rates of obesity and metabolic comorbidities, intragastric balloons occupy a distinct role between conservative medical therapy and bariatric surgery, offering a reversible, minimally invasive option that can be integrated into comprehensive care plans.

Clinical outcomes and patient experience remain central to adoption. Recent procedural optimizations and post-placement follow-up protocols have reduced adverse event profiles while improving sustained weight reduction when combined with behavioral and pharmacologic support. Payers and health systems are increasingly focused on patient selection criteria, real-world durability of outcomes, and cost-effectiveness relative to other interventions. Consequently, commercial strategies now emphasize robust clinical evidence, streamlined supply logistics, and partnerships with bariatric centers, outpatient specialty clinics, and hospital systems to embed intragastric balloons into longitudinal obesity care pathways.

Given this environment, manufacturers and health system leaders must balance device innovation with pragmatic considerations around training, reimbursement pathways, and center readiness. The interplay of regulatory evolution, clinician education, and patient demand will continue to shape positioning and uptake across diverse care settings.

How technological refinements, integrated care pathways, and provider delivery models are reshaping clinical adoption and commercial differentiation

The intragastric balloon landscape is undergoing transformative shifts driven by technological refinement, multidisciplinary care models, and heightened focus on personalized therapy. Device innovators have introduced modifications in fill media, anchoring mechanisms, and retrieval techniques, which, together with improved patient selection protocols, have reduced complication rates and expanded candidate eligibility. Concurrently, the integration of behavioral counseling, digital monitoring, and adjunctive pharmacotherapy has shifted outcomes toward more durable weight management, prompting clinicians to view balloons as one component of a comprehensive treatment strategy rather than a stand-alone cure.

Market-facing dynamics are also changing. Providers are reconfiguring service lines to offer outpatient and specialty clinic-based procedures, minimizing hospital resource utilization and enhancing patient convenience. At the same time, manufacturers are differentiating through bundled value propositions that include clinician training, follow-up programs, and patient engagement tools. Regulatory scrutiny remains rigorous, but clearer guidance has helped streamline adoption in regions where reimbursement frameworks are adapting to recognize long-term health economic benefits of obesity interventions.

As a result, competition is increasingly centered on post-procedural outcomes, care pathway integration, and commercial models that reduce friction for providers and patients. These shifts favor stakeholders who can demonstrate clinical efficacy within coordinated care programs and who can support scalable, low-complexity delivery models across a range of clinical settings.

Assessment of how 2025 United States tariffs have altered supply chain strategies, pricing transparency, and procurement practices across the intragastric balloon ecosystem

The cumulative impact of tariff changes in the United States during 2025 has prompted device manufacturers, distributors, and provider procurement teams to reassess supply chain resilience and cost allocation for imported intragastric balloons and related consumables. Tariff adjustments have led to higher landed costs for certain categories of components and finished devices, prompting manufacturers to pass some cost increases downstream while simultaneously exploring alternative sourcing and localized manufacturing to protect margins. Procurement teams within hospitals and clinics have responded by renegotiating contracts, seeking longer-term supply agreements, and prioritizing suppliers with diversified production footprints.

Beyond unit costs, tariffs have amplified the strategic importance of inventory planning and lead-time visibility. Providers have increased engagement with distributors to secure predictable deliveries and to minimize exposure to sudden tariff-driven price swings. Some manufacturers have accelerated investments in regional manufacturing capabilities and third-party partnerships to mitigate tariff risk and improve responsiveness to clinical demand. Regulatory compliance, customs clearance complexity, and documentation requirements have also consumed additional administrative resources, prompting supply chain teams to invest in customs expertise and digital tracking tools.

In this context, commercial strategies that emphasize transparency around total landed costs, warranty coverage, and service-level commitments have gained traction. Stakeholders that proactively adapt contracting practices, hedge supply routes, and communicate clear cost implications to purchasers will be better positioned to sustain adoption momentum despite tariff-induced headwinds.

In-depth segmentation analysis linking device type, end-user setting, distribution route, and clinical application to commercialization and clinical adoption imperatives

Understanding segmentation dynamics is essential to shaping product development and commercial outreach. Based on Type, market is studied across Endoscopic and Non Endoscopic, with Endoscopic further studied across Gas and Liquid; this distinction influences device design, procedural technique, and post-placement management, and it guides which clinical teams are engaged for training and follow-up. Separately, based on End User, market is studied across Bariatric Centers, Clinics, and Hospitals, with Clinics further studied across Outpatient Clinics and Specialty Clinics; differences in infrastructure, anesthesia capability, and care pathways across these settings determine preferred device profiles and service bundles. Furthermore, based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacies, and distribution strategy must consider inventory management, clinician procurement processes, and the role of specialty distributors in supporting training and on-site logistics. Finally, based on Application, market is studied across Preoperative Optimization and Weight Loss, and this clinical segmentation affects referral patterns, payer interactions, and the alignment of patient support services.

Taken together, these segmentation axes reveal where clinical demand concentrates and where commercialization efforts should be tailored. For example, gas-filled versus liquid-filled endoscopic options appeal to different patient groups and procedural workflows, while clinics and outpatient specialty settings may prioritize devices that minimize procedure time and recovery needs. Distribution partnerships with hospital pharmacies will differ markedly from retail pharmacy models in terms of supply chain transparency and clinician interactions. Application-based segmentation underscores the need for outcome data specific to preoperative optimization versus primary weight reduction, which in turn shapes messaging to surgeons, primary care physicians, and multidisciplinary care teams.

In practical terms, manufacturers should align device features, training programs, and commercial terms with the dominant segmentation profiles in their target geographies, ensuring that product variants and service offerings match the operational realities of the end users and distribution partners they intend to serve.

Regional adoption drivers, regulatory variability, and distribution imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics significantly influence clinical adoption patterns, regulatory pathways, and distribution strategies for intragastric balloons. In the Americas, established bariatric centers and a growing number of outpatient clinics are integrating intragastric balloons into therapy mixes as payers and providers place greater emphasis on non-surgical interventions. This region favors solutions that demonstrate reproducible outcomes in diverse patient populations and that can integrate with existing multidisciplinary obesity programs. Meanwhile, Europe, Middle East & Africa present a heterogeneous landscape where regulatory frameworks, reimbursement environments, and clinical practice patterns vary widely; in some markets, centralized hospital systems and national guidelines accelerate adoption, whereas in others, variability in payer coverage and clinician experience necessitate targeted education initiatives and local evidence generation. Asia-Pacific exhibits rapid uptake driven by rising prevalence of obesity and metabolic disease, diverse care delivery models, and an emphasis on minimally invasive alternatives. In several Asia-Pacific markets, high-volume specialty clinics and consumer interest in less invasive options have encouraged manufacturers to develop localized training and patient support programs.

Across regions, supply chain considerations, regulatory timelines, and the maturity of reimbursement pathways shape go-to-market approaches. For example, regions with strong outpatient clinic networks may prioritize devices optimized for day-case procedures and limited anesthesia resources. Conversely, where hospital-centric care dominates, integrated service offerings that include clinician training, post-procedural monitoring, and durable follow-up will be more impactful. Effective regional strategies blend global clinical evidence with locally relevant real-world data and stakeholder engagement to build durable acceptance among clinicians, payers, and patients.

Competitive company strategies emphasizing device innovation, bundled clinical services, and partnership models to drive adoption and operational scale

Key companies operating in the intragastric balloon arena have converged around several strategic imperatives: clinical differentiation, service-oriented commercialization, and operational scalability. Leading device developers invest in iterative device design improvements to reduce adverse events and to simplify placement and removal workflows. Firms are also expanding portfolio breadth to include both gas-filled and liquid-filled endoscopic options, enabling them to address diverse clinician preferences and patient physiologies. Beyond devices, companies increasingly bundle training, patient engagement platforms, and follow-up services to improve outcomes and to reduce the burden on provider staff.

Strategic partnerships have become a common pathway to accelerate adoption; alliances with bariatric centers, specialty clinics, and distribution partners allow companies to demonstrate real-world effectiveness while building referral networks. Some players have pursued regional manufacturing relationships to enhance supply resilience and to optimize landed cost structures. In parallel, competitive differentiation is being sought through evidence generation-prospective registries, multi-center studies, and health economic analyses-to support payer engagement and to inform clinical guidelines. Companies that successfully balance product innovation with scalable service delivery and robust clinical evidence are positioning themselves to win favor among large health systems, outpatient providers, and specialist clinics seeking predictable outcomes and streamlined operations.

Actionable commercial, clinical, and supply chain measures for leaders to build resilient adoption pathways and align stakeholders around value delivery

Industry leaders should prioritize an integrated approach that aligns clinical evidence, service delivery, and supply chain resilience to accelerate sustainable adoption of intragastric balloon solutions. First, invest in robust real-world evidence generation and patient-reported outcomes to substantiate clinical claims across both preoperative optimization and standalone weight loss applications, thereby easing payer discussions and clinician acceptance. Second, create comprehensive training and credentialing pathways tailored to the needs of bariatric centers, outpatient clinics, and specialty clinics to reduce procedural variability and enhance safety profiles. Third, diversify sourcing and logistics strategies to mitigate exposure to tariff volatility and to shorten lead times, including localized manufacturing partnerships where commercially feasible.

Additionally, adapt commercial models to support different purchasing behaviors across hospital pharmacies and retail pharmacy channels by providing transparent total-cost-of-care communications and flexible contracting terms. Leverage digital patient engagement tools and multidisciplinary support programs to improve adherence to lifestyle interventions and to extend follow-up capabilities without overburdening clinical staff. Finally, pursue strategic collaborations with payer stakeholders to establish value-based arrangements or coverage pathways that reflect the long-term clinical and economic benefits of integrated obesity care. Collectively, these actions will strengthen the value proposition for intragastric balloons and support durable, scalable adoption across care settings.

Comprehensive mixed-methods research approach combining clinical interviews, regulatory review, and supply chain analysis to validate actionable insights

The research underpinning this report employed a mixed-methods approach to ensure that insights reflect both clinical realities and commercial dynamics. Primary inputs included structured interviews with clinicians across bariatric centers, outpatient specialty clinics, and hospital-based programs, as well as discussions with procurement leads and distribution partners active in hospital pharmacy and retail pharmacy channels. Secondary inputs comprised regulatory publications, clinical trial registries, and peer-reviewed literature focusing on device safety, efficacy, and patient-reported outcomes. Triangulation of these data sources enabled identification of consistent themes around device performance, procedural workflows, and barriers to adoption.

Analytical methods included comparative assessment of device design attributes-such as fill media and delivery systems-against procedural outcomes and care setting requirements. Supply chain and commercial impact analysis incorporated scenario testing to evaluate responses to tariff changes and sourcing disruptions, with attention to procurement behavior across different end-user environments. Throughout, findings were validated with clinician advisory panels and supply chain experts to ensure practical relevance and to surface actionable implications for manufacturers, providers, and payer stakeholders. The methodology emphasizes transparency in data sources and analytical assumptions while prioritizing clinical applicability and strategic utility for decision-makers.

Concluding synthesis highlighting the clinical, commercial, and operational levers that will determine successful adoption across diverse care settings

In summary, intragastric balloons have matured into a strategically important tool within contemporary obesity care, positioned between conservative medical management and surgical options. Device innovations, improved clinical protocols, and integrated care models have collectively enhanced safety and broadened applicability, creating meaningful opportunities for adoption across bariatric centers, outpatient clinics, and hospital systems. Nevertheless, commercial success depends on more than device performance; it requires demonstrable outcomes, clear reimbursement pathways, resilient supply chains, and scalable service models that support clinician training and patient engagement.

Tariff fluctuations and regional regulatory variability introduce complexity, but they also present opportunities for manufacturers to differentiate through transparent pricing, localized partnerships, and evidence-based commercial strategies. By aligning product development with end-user needs-taking into account the distinctions between endoscopic gas versus liquid options, varied clinic infrastructures, and distribution channel requirements-stakeholders can create compelling value propositions that resonate with providers and payers. The path forward favors those who couple clinical rigor with pragmatic commercialization to deliver reproducible outcomes and efficient care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of adjustable intragastric balloons enabling personalized weight management protocols
  • 5.2. Integration of intragastric balloon therapy with digital health platforms for remote patient monitoring and engagement
  • 5.3. Development of biodegradable intragastric balloon systems designed to eliminate endoscopic removal procedures
  • 5.4. Clinical studies assessing combined use of intragastric balloons with GLP-1 agonists for synergistic weight loss outcomes
  • 5.5. Emergence of shape-memory polymer balloons offering dynamic volume adjustment in response to gastric motility changes
  • 5.6. Regulatory clearances for novel air-filled intragastric balloons minimizing patient discomfort and procedural complexity
  • 5.7. Expansion of intragastric balloon applications to address nonalcoholic fatty liver disease and metabolic syndrome management
  • 5.8. Strategic collaborations between endoscopy device makers and telehealth providers to broaden balloon therapy accessibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intragastric Balloon Market, by Type

  • 8.1. Endoscopic
    • 8.1.1. Gas
    • 8.1.2. Liquid
  • 8.2. Non Endoscopic

9. Intragastric Balloon Market, by End User

  • 9.1. Bariatric Centers
  • 9.2. Clinics
    • 9.2.1. Outpatient Clinics
    • 9.2.2. Specialty Clinics
  • 9.3. Hospitals

10. Intragastric Balloon Market, by Distribution Channel

  • 10.1. Hospital Pharmacies
  • 10.2. Retail Pharmacies

11. Intragastric Balloon Market, by Application

  • 11.1. Preoperative Optimization
  • 11.2. Weight Loss

12. Intragastric Balloon Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intragastric Balloon Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intragastric Balloon Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Apollo Endosurgery, Inc.
    • 15.3.2. Allurion Technologies, Inc.
    • 15.3.3. Obalon Therapeutics, Inc.
    • 15.3.4. ReShape Lifesciences, Inc.
    • 15.3.5. Spatz Medical, Inc.
    • 15.3.6. MedSil, UAB
    • 15.3.7. Silimed, S.A.
    • 15.3.8. ENDALIS GmbH
    • 15.3.9. GI Dynamics, Inc.
    • 15.3.10. BARIATRX Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAGASTRIC BALLOON MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAGASTRIC BALLOON MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAGASTRIC BALLOON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 230. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 231. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 234. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 235. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 272. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 273. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 276. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 277. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 286. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 287. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 290. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 291. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 312. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 328. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 329. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 336. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 337. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 338. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 339. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 340. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 341. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 342. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 343. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)

TABLE 344